Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer

An increasing prostate-specific antigen (PSA) level during radium therapy for metastatic castrate-resistant prostate cancer (mCRPC) is not an uncommon phenomenon, especially in heavily pretreated patients; however, an increasing PSA level does not always indicate progressive disease. Bone scan, ches...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Genitourin Cancer
Egile Nagusiak: Modi, Dipenkumar, Hwang, Clara, Mamdani, Hirva, Kim, Seongho, Gayar, Hesham, Vaishampayan, Ulka, Joyrich, Richard, Heath, Elisabeth I.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849387/
https://ncbi.nlm.nih.gov/pubmed/27053499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2016.03.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak